Voorhees Seth Van's Net Worth

$84.9 Thousand

Estimate Recalculated Sep 9, 2024 12:34AM EST

Who is Voorhees Seth Van

Voorhees Seth Van does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AMERICAN PACIFIC CORP, PDS Biotechnology Corp, RESEARCH FRONTIERS INC, and NRX Pharmaceuticals, Inc..

SEC CIK

Voorhees Seth Van's CIK is 0001284934

Past Insider Trading and Trends

2006 was Voorhees Seth Van's most active year for acquiring shares with 15 total transactions. Voorhees Seth Van's most active month to acquire stocks was the month of January. 2020 was Voorhees Seth Van's most active year for disposing of shares, totalling 5 transactions. Voorhees Seth Van's most active month to dispose stocks was the month of January. 2021 saw Voorhees Seth Van paying a total of $149,999.50 for 220,447 shares, this is the most they've acquired in one year. In 2020 Voorhees Seth Van cashed out on 155,091 shares for a total of $0.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AMERICAN PACIFIC CORP

VP, CFO & Treasurer
Updated Mar 03, 2006
Form 4
5.89K
$5.71
$33.65K
Mar 03, 2006
60.89K
Purchase
Mar 01
Form 4
15.00K
$5.58
$83.63K
Feb 21, 2006
55.00K
Purchase
Feb 17
Form 4
40.00K
Oct 25, 2005
40.00K
Grant
Sep 13
Form 3
Apr 06, 2004
Showing 4 results

PDS Biotechnology Corp

Chief Financial Officer
Updated Jun 17, 2021
Form 4
17.65K
$8.50
$150.00K
Jun 17, 2021
17.65K
Purchase
Jun 15
Form 4
202.80K
Jan 06, 2021
202.80K
Grant
Jan 04
Form 3
Jan 06, 2021
Showing 3 results

RESEARCH FRONTIERS INC

CFO & VP-Business Development
Updated Feb 24, 2020
Form 4
-4.76%
-63.54K
$1.36
$124.96K
Feb 24, 2020
1.27M
Options
Feb 21
Form 4
7.01%
20.00K
Jan 02, 2020
305.19K
Grant
Dec 31
Form 4
7.54%
20.00K
Jun 17, 2019
285.19K
Grant
Jun 13
Form 4
29.30%
60.09K
May 04, 2018
265.19K
Grant
May 03
Form 4
17.13%
30.00K
Jan 03, 2018
205.10K
Grant
Dec 31
Form 4
2.97%
4.00K
$1.15
$4.60K
Sep 13, 2017
138.90K
Purchase
Sep 12
Form 4
16.66%
25.00K
Jan 03, 2017
175.10K
Grant
Dec 31
Form 4
36.33%
40.00K
Jan 04, 2016
150.10K
Grant
Dec 31
Form 4
50.00%
36.70K
Jan 05, 2015
110.10K
Grant
Dec 31
Form 4
56.73%
75.40K
$5.45
$10.90K
Jun 19, 2014
220.30K
Purchase
Dec 31 - Jun 19
Form 4
73.40K
Jan 02, 2014
218.30K
Grant
Dec 31
Form 4
73.27%
56.20K
Jan 03, 2013
144.90K
Grant
Jan 01
Form 4
113.06%
40.70K
Jan 04, 2012
88.70K
Grant
Jan 01
Form 4
100.00%
24.00K
$8.65
$207.60K
Feb 14, 2011
48.00K
Purchase
Feb 10
Form 3
Jan 10, 2011
24.00K
Showing 15 results

NRX Pharmaceuticals, Inc.

CHIEF FINANCIAL OFFICER
Updated Dec 19, 2022
Form 4
183.63%
30.00K
$1.10
$33.00K
Dec 19, 2022
46.34K
Purchase
Dec 16
Form 4/A
16.34K
$1.11
$18.22K
Dec 19, 2022
16.34K
Purchase
Nov 25
Form 4
174.62%
16.34K
$1.12
$18.22K
Nov 28, 2022
25.69K
Purchase
Nov 25
Form 3
Jun 29, 2022
Showing 4 results